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Wereportthesuccessfulclassiﬁcation,byartiﬁcialneuralnetworks(ANNs),of 1HNMRspectroscopicdatarecordedonwhole-cell
culture samples of four diﬀerent lung carcinoma cell lines, which display diﬀerent drug resistance patterns. The robustness of the
approach was demonstrated by its ability to classify the cell line correctly in 100% of cases, despite the demonstrated presence
of operator-induced sources of variation, and irrespective of which spectra are used for training and for validation. The study
demonstrates the potential of ANN for lung carcinoma classiﬁcation in realistic situations.
1.Introduction
Nuclear magnetic resonance spectroscopy (NMR, or MRS)
has enormous potential for the study of biochemical and
physiologicalchangesincancertissues,duetoitsnoninvasive
nature and the large quantity of speciﬁc molecular infor-
mation it can generate. Despite the sensitivity limitations of
the technique, the inherent complexity of the spectra, and
inevitable presence of overlapping resonances, there have
been several successful NMR-metabonomics studies of cell
tissue culture and culture extracts. The focus has been on
elucidating the physiopathology of tumors and tumor cells,
their drug toxicology and drug resistance, often with a view
to identifying diagnostic markers [1–8]. A further signiﬁcant
complication in such studies arises from variability in the
metabolite proﬁle from sample to sample. This reﬂects many
factors[9]includingminorvariationsingrowingconditions,
the biochemical heterogeneity of the growing cells, the eﬀect
ofdiﬀerentbatchesofsera(ifused),andvariationsincelland
sample preparation. These additional factors may mask the
inherent metabolite distribution, which may be diagnostic of
the pathophysiological state of interest.
Experimental complications and diﬃculties also com-
promise the extraction of critical information from in vivo
MRS experiments. In this case, the problems arise from
the use of diﬀerent MR-protocols, which aﬀect the quality
of the water suppression, diﬀerences in echo time and in
the baseline, and so forth. While the causes are diﬀerent in
origin, they have a similar eﬀect on the application. For both
forms of magnetic resonance, many of these issues can, in
principle, be addressed by improved experimental design,
however, it is common for additional sources of variance
to be identiﬁable only after extensive experimentation. In
addition to technical issues are the natural physiological
variability and the individual treatment history of the
subject. As a result, there is an ongoing requirement for the
development of magnetic resonance-based diagnostics using
advanced statistical-, or other data-, analysis techniques
which can reduce or compensate for additional sources of
variability.2 Journal of Biomedicine and Biotechnology
1H NMR spectra of intact tissues or whole-cell samples
are inherently complex due to the large number of con-
tributing species which results in signiﬁcantly overlapping
resonance signals. Cell membranes also produce magnetic
ﬁeld inhomogeneity, further broadening the spectra [10].
In the case of cancer cells, a signiﬁcant proportion of
the lipids reside in a ﬂuid environment and hence appear
in the liquid-state 1H spectra as strong “mobile-lipid”
resonances [7, 8, 11]. Although the identiﬁcation of the
major resonances in 1H NMR spectra can be used to
characterisethemetaboliteproﬁle,thecomplexityofthedata
sets usually necessitates the use of data reduction and pattern
recognition techniques. These can provide information on
the biochemical and physiological changes in cancer tissues,
related to their physiopathology, drug toxicology, and drug
resistance [12, 13]. Prominent amongst such techniques is
principal component analysis (PCA), [14, 15]wh i c hi n v o l v e s
diagonalisation of the spectral correlation or covariance
matrix to identify independent sourcesof variance(principal
components) across the set of spectra, and ranking of the
components by their contribution to the overall variance.
Thus, PCA is an unsupervised approach to data reprojection
that can reveal the presence of classes, it has been applied to
a variety of problems in biological science [16, 17].
Artiﬁcial Neural Networks (ANNs) belong to the so-
called Artiﬁcial Intelligence group of methods, which were
inspired by neurobiology and by the architecture of the
human brain [18]. In recent times, these approaches have
found applications in many branches of science. For exam-
ple, they have been used in chemotaxonomy to classify
limpets [19] from HPLC mass spectrometric data and
in the identiﬁcation of insect species from morphological
measurements [20]. ANNs can be used to model data where
the relations, or functions, are not known.
There have been some reports of the use of artiﬁcial
intelligence and network methods in medical diagnostics
which have involved analysis of magnetic resonance spec-
troscopic data. El-Deredy et al. [21] used ANNs to achieve
reasonable prediction of the measured in vitro chemother-
apeutic response from 1H NMR of glioma biopsy extracts.
More recently, Suna et al. [22] demonstrated the diagnostic
potential of unsupervised approaches to classiﬁcation by
successfully analysing simulated 1H NMR spectra using self-
organising maps. This approach allowed the identiﬁcation of
stages along a metabolic pathway ranging from “normolip-
idaemic” to “metabolic syndrome”. Tate and coworkers [23]
reported the trial of an automated decision support system
for classiﬁcation of brain tumors from in vivo MRS, which
showed a small but signiﬁcant improvement in diagnostic
accuracy over spectroscopy used and interpreted on its own.
In recent work [24], we reported PCA of 1HN M R
spectra recorded for a group of human lung carcinoma cell
lines in culture and 1H NMR analysis of extracts from the
same samples. The samples studied were cells of lung tumor
origin with diﬀering chemotherapy drug resistance patterns.
For whole-cell samples, it was found that the statistically
signiﬁcant causes of spectral variation were an increase in
the choline and a decrease in the methylene and mobile
lipid 1H resonance intensities, which were correlated with
our knowledge of the level of resistance displayed by the
diﬀerent cell lines. In this paper, we investigate the use of
artiﬁcial neural network (ANN), a supervised method, to
classify lung carcinoma. Two sets of whole-cell 1HN M R
spectra will be examined. These were recorded for two
groupsofhumanlung carcinomacelllines,theseweregrown
in culture and characterised over two diﬀerent periods by
two diﬀerent groups of researchers (each consisting of a
biologist and a spectroscopist), who both adhered to the
sameexperimentalprotocolandusedthesamespectrometer.
The cell lines studied include (i) the parent cell line DLKP,
a human squamous nonsmall cell lung carcinoma; (ii)
DLKP-A; (iii) DLKP-A5F, two resistant daughter lines; (iv)
A549, a human lung adenocarcinoma cell line. The study
also examines the capability of supervised techniques to
compensate for experimental sources of variance, which may
include operator bias and the cell culture growth process
and in particular provide a test case for the application of
ANN architectures in the identiﬁcation and monitoring of
resistance states in cancer tissue by MRS.
2. Experimental
2.1. Cell Samples. T h ec e l ll i n e sD L K P[ 25, 26], DLKP-A
[27], DLKP-A5F [28] ,a n dA 5 4 9w e r eg r o w ni nc u l t u r et o
approximately 70–80% conﬂuency in 175cm2 tissue culture
ﬂasks. Culture conditions were as follows: DLKP, DLKP-
A, and DLKP-A5F and were cultured in minimal essential
medium/Hams F12 (1:1, v/v) supplemented with 5% fetal
calf serum and 2mM L-glutamine. A549 was cultured in
Dulbecco’s modiﬁed Eagle’s medium/Hams F12 (1:1, v/v)
supplemented with 5% fetal calf serum. Cells were cultured
as monolayers in tissue culture ﬂasks and incubated at 37
◦C.
Ac e l lc o u n tw a sp e r f o r m e da n dc .5× 107 cells were
separated and pelleted. These were then resuspended in
deuterated PBS buﬀer and were kept in a container at 37
◦C
before the start of the NMR measurements. The methods
used were described in detail previously [24]. DLKP cells
express a small amount of the multidrug resistance protein-1
(MRP-1) MDR drug eﬄux pump [25, 26]. DLKP-A [27]i sa
highly resistant clone of DLKP, which overexpresses the P-gp
drug eﬄux pump. DLKP-A5F [28]w a sd e r i v e df r o mD L K P
by a diﬀerent drug exposure proﬁle, it is also highly drug
resistant. A549 is an unrelated human lung adenocarcinoma
celllinewhichwasobtainedfromtheAmericanTypeCulture
Collection.
The ﬁrst group of 13 samples, G1 13 21, were grown by
a biologist during a six-month period, they were analysed by
a ﬁrst NMR spectroscopist. G1 13 21 contained 21 spectra
and so was relatively sparse, it comprised DLKP [4 samples,
6 spectra], DLKP-A [4, 6], DLKP-A5F [3, 5], and A549
[2, 4]. The second group of 17 samples, G2 17 33, was
grownindependently,byasecondbiologistduringalatersix-
month period and was analysed by a second spectroscopist
[24]. G2 17 33 contained 33 spectra, it comprised DLKP
[3, 6], DLKP-A [5, 10], DLKP-A5F [5, 9], and A549 [4, 8].
Thus for the integrated study presented here, a total of 30
samples were prepared and 54 1Hs p e c t r aw a sr e c o r d e d .T h e
same protocols and methods were used by all the researchersJournal of Biomedicine and Biotechnology 3
for cell growth and NMR spectroscopy. The biologist and
spectroscopist who produced G1 13 21 will be collectively
referred to as R1, and the biologist and spectroscopist who
produced G2 17 33 will be referred to as R2. Due to the
signiﬁcant work involved in producing the large number of
cells required for each spectrum, the number of samples in
the study is inevitably somewhat limited. However, the total
data set is larger than those usually reported in the analysis
of NMR data by pattern recognition methods [16, 17, 29].
2.2. 1HN M RS p e c t r o s c o p yo fI n t a c tC e l l s .NMR spectra
of the intact cell samples were recorded in deuterated
PBS buﬀer on a Bruker DPX 400 spectrometer operating
at 400.13MHz for 1H. Before all NMR experiments, the
sample temperature was calibrated and controlled at 36.4 ±
0.2
◦C using an internal ethylene glycol thermometer (80%
solution of ethane-1,2-diol in dimethyl sulfoxide-d6). 1H
NMR spectra were acquired, without spinning, using WET
[30] solvent suppression, with two Carr-Purcell-Meiboom-
Gill (CPMG) echoes appended, using an echo delay of 1ms
[10]. Chemical shifts were referenced to an external 0.1%
solution of sodium trimethylsilyl-[2,2,3,3-d4]-propionate
(TSP) in D2O. All experiments were performed with a
spectral width of 5200Hz, an acquisition time of 3.15s,
and relaxation delay of 2s. Three acquisition schemes were
used to record the one-dimensional 1H NMR spectra, all
amounting to 128 scans. The ﬁrst scheme (I) employed
cycles of 16 dummy scans followed by four acquisition scans,
(16,4)32,givinganacquisitiontimeof3/4hour.Inthesecond
scheme (II), 16 dummy scans were applied once prior to
acquisition 16((0,16)8), giving an acquisition time of 13
minutes. In the third scheme (III), 16 dummy scans and 128
acquisition scans were collected into 32K data points, giving
an acquisition time of 15 minutes. The time taken from
resuspension to the start of data acquisition was typically
less than 3/4 hour, and never more than 1 hour. All the data
presented were recorded within 1 hour.
For the ﬁrst group of 13 samples (G1 13 21) in the
study, the acquisition schemes (I) and (II) were used for
eachsample.Forthesecondgroupof17samples(G2 17 33),
all three schemes were tested for each sample. Hence, the
greater number of repeat spectra is for the second group.
The inclusion of multiple spectra in the analysis from the
same sample tests the stability of the samples over the time of
the analysis. The insensitivity of the spectra to the sampling
scheme used demonstrates that the samples do not change,
for example, due to sedimentation, over the timescale that a
single spectrum is acquired.
2.3. PCA Analysis. In the spectral region from 1.08 to
1.20ppm, ethanol was observed, which was probably the
result of endogenous processes. However, its intensity was
highly variable, even within the same cell line, so this region
was excluded from the analysis. The region containing the
residual water resonance signal (3.56–6.05ppm) was also
excluded. The region above 6.05ppm contained no features
of suﬃcient intensity for reliable quantiﬁcation, given the
linewidth. For this study, we chose, as descriptors, the
integrals over chemical shift regions (bins) of size 0.04ppm
Input
Inputi
. . .
wij
wij
Output
Outj
Hidden layers
Figure 1: Schematic representation of a four-layer ANN architec-
ture.
[12] which was found to produce the clearest separation of
the cell types in the scores plots and the least noise in the
corresponding loadings plots. Thus, the NMR spectra were
reduced to 71 descriptors, with bin centres in the range 0.60–
1.04, 1.24–3.56ppm. We adopted the conventional approach
[31] of normalisation relative to the total sum of the bin
intensities in the region of interest. All the measures were
implemented through writing an MATLAB (version 6.5.1,
The Mathworks Inc.) code making use of the built in
eigensolver.
2.4. ANN Analysis. ANNs are a sophisticated computational
modelling tool, which can be used to solve a wide variety
of complex problems. The attractiveness of ANNs comes
from their capability to “learn” and/or model very complex
systems and from the possibility of using them in classiﬁ-
cation. An ANN is a computational model formed from a
certain number of single units, artiﬁcial neurons, or nodes,
connected with coeﬃcients (weights), wij,w h i c hc o n s t i t u t e
the neural structure. Many diﬀerent neural network archi-
tectures can be used. One of the most common is the
feed forward neural network of multilayer perceptions. The
network is conventionally constructed with three or more
layers, that is, input, output, and hidden layers, Figure 1.
Each layer has a diﬀerent number of nodes. The input
layer receives the information about the system (the nodes
of this layer are simple distributive nodes, which do not
alter the input value at all). The hidden layer processes the
information initiated at the input, while the output layer is
the observable response or behaviour. The inputs, inputi,
multiplied by connection weights wij are ﬁrst summed and
then passed through a transfer function to produce the
output, outi. The determination of the appropriate number
of hidden layers and number of hidden nodes in each layer
is one of the most critical tasks in ANN design. Unlike the
input and output layers, one starts with no prior knowledge
of the number and size of hidden layers.4 Journal of Biomedicine and Biotechnology
The use of ANN consists of two steps: “Training”a n d
“Prediction”. The “Training” consists ﬁrst of selecting input
and output data for the network. This data is referred to
as the training set. In the training phase, where actual data
mustbeused,theoptimumstructure,weightcoeﬃcientsand
biases of the network are identiﬁed. Training is considered
complete when the neural networks achieve the desired
statistical accuracy, that is, when they produce the required
outputs for a given sequence of inputs. A good criterion to
ﬁnd the correct network structure and therefore to stop the
learning process is to minimise the root mean square (RMS)
error as follows:
RMS =
   
N
i=1
M
j−1

yij −outij
2
N ×M
,( 1 )
where yijistheelementofthematrix(N×M)forthetraining
s e to rt e s ts e t ,a n do u t ij is the element of the output matrix
(N × M) of the neural network, where N is the number of
variables in the pattern, and M is the number of samples.
RMS gives a single number, which summarises the overall
error.
After a supervised network performs well on training
data, it is important to check its performance with data
that has not been used in training. This process is called
veriﬁcation. This testing is critical to insure that the network
has not simply memorised the training set but has learned
the general patterns involved within an application. At this
stage, other input data are submitted to the network in
order to evaluate if it can predict the outputs. In this
case, the outputs are already known, but they are not
shown to the network. The predicted value is compared
to the experimental one to see how well the network is
performing. If the system does not give reasonable outputs
for this test set, the training period is not over or the
network is able to model the data but cannot predict
them.
In this work, ANN was used as a supervised method
where a training data set was created from the library of
NMR spectra, and the lung carcinoma classiﬁcation of this
training data set was known. The backpropagation method
was used throughout. Firstly, the optimal ANN architecture
was searched for and when the correct classiﬁcation in the
training phase was obtained, the usefulness of the created
database and the prediction power of the networks were
validated using an independent veriﬁcation set. For the
ANN analysis, we used 72 inputs; the 71 binned NMR
intensities and the identity of the pairs of researchers (R1
and R2) as numbers 1 and 2. For output 4, nominal values
were used, these identify the four cell lines, DLKP, DLKPA,
DLKP-A5F, and A549, for which there were 12, 16, 14,
and 12 spectra, respectively. All calculations were performed
using the software Trajan Neural Network Simulator, Release
3.0D. (Trajan Software Ltd 1996–1998, UK), on a standard
PC computer running Microsoft Windows Professional XP
2000.
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Figure 2:Typical400MHz 1HNMRspectraofDLKPlungcarcino-
ma whole cells. (a) CH3,( b )C H 2,( c )C H 2CH=CH, (d) CH2COO,
(e) =CHCH2CH=,( f )H C =CH/CHOCOR. The spectral regions
used for statistical analysis (0.60–1.04 and 1.24–3.56ppm) are
indicated.
3. Results
3.1. 1H NMR Spectroscopy of Whole Cells. A typical 1HN M R
spectrum of intact DLKP cells is shown in Figure 2.T h e
appearance of the spectra and the assignment suggested
below are broadly similar for all the cell samples analysed.
A tentative assignment which is consistent with the literature
[2,4,32,33]isincludedintheﬁgure[24].Directquantitative
analysis of the whole-cell spectra is hampered by the
potential multiple contributions from diﬀerent metabolites
to any given resonance line by the nonlorentzian lineshapes
and by the broadness of the resonance lines. The resonances
in the downﬁeld region arise from species that are at
low concentration, so quantiﬁcation is precluded by the
sensitivity limitations of the NMR measurement.
3.2. PCA Visualization of Whole-Cell Spectra. The binned
NMR spectra of the intact cells were analysed using PCA.
ThescoresplotsareshowninFigure 3.Separationofthefour
cell types, within each of the two data sets, is apparent using
the ﬁrst two PCs, demonstrating that resistance type can
be classiﬁed by PCA. It also demonstrates that the samples
were stable over the course of the experiment and that
the spectra are insensitive to the NMR sampling scheme.
Loadings analysis shows that, for each data set, the spectral
regions that contribute signiﬁcantly to the ﬁrst two principal
components are from 1.24 to 1.50ppm, corresponding to
overlapped resonances from lipid methylenes and lactate
methyls, and from 2.90 to 3.40ppm, corresponding to
overlapped resonances from N-methyl signals in the choline
moieties of phosphatidylcholine, phosphocholine, and glyc-
erophosphocholine. The contribution from other spectral
regions to these two principal components is marginal.
Despite the fact that the same spectral regions allow
separation within each data set, separation using PCA fails
when the two sets of spectra are combined into one; see Sup-
plementary Material available at doi:10.1155/2011/158094. It
is apparent that, in addition to the metabolite diﬀerencesJournal of Biomedicine and Biotechnology 5
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Figure 3: PCA scores plots for A549, DLKP, DLKPA, and DLKP-A5F, whole-cell data. Analysis is shown for G1 13 21 (a), G2 17 33 (b). The
right hand panel is reproduced from [24] with permission.
of biological interest, there are subtle diﬀerences between
G1 13 21 and G2 17 33 in the distribution of metabolites,
which prevent classiﬁcation of the entire (54 spectra) data
set.Theloadingsanalysisindicatescontributionsfromacross
the spectral range, which may suggest variations in more
than one metabolite. These spectral diﬀerences arise despite
stringent eﬀorts of the second group of researchers to adhere
totheoriginalexperimentalprotocolsandarereﬂectedinthe
fact that there is not a simple correspondence between the
orientation of the ﬁrst two principal components between
the two sets of spectra, Figure 3.
3.3. ANN Analysis of Whole-Cell Spectra. ANN analysis
consists of separate training and veriﬁcation steps. For
this study, we adopted the strategy of choosing multiple
veriﬁcation sets of spectra at random from the 54 spectra
available. In training, the ﬁrst aim is to ﬁnd an optimal ANN
architecture to enable classiﬁcation of the training data set.
Several architectures of three up to four layered structures
were examined for this purpose.
3.4. 3-Layers Architecture. Initially we adopted the simplest
3 layers architecture, in which case the search of the
optimal architecture consists of optimising the number of
nodes in the single hidden layer, eﬀectively determining
the corresponding weights, wij, to minimize the RMS (root
mean square error) value according to (1). For our analysis,
the RMS value ceases to decrease signiﬁcantly above 5 to 6
nodes, Figure 4, we therefore used networks with 6 hidden
nodes for veriﬁcation. This optimal architecture will be
labelled(72, 6, 4), with it we obtained anRMS = 1.38 × 10−3.
Figure 4 illustrates the process of searching for the optimal
network architecture.
In spite of the fact that very low values for the residual
mean squares were achieved using the (72, 6, 4) architecture,
theappropriatenessofthearchitectureandofthetraining set
0
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Figure 4: Plot of residual mean squares as a function of the number
of nodes in the hidden layers, in the three-layers network (), and
in the second (Δ) and third () layers of the four-layers network.
For the networks labelled (Δ), 3 nodes were used in the third layer;
and for the networks labelled (), 4 nodes were used in the second
layer.Thelineshavenophysicalmeaning;theyareincludedtobetter
illustrate the optimal number of nodes.
wasthentestedwithvariousveriﬁcationsets,thatis,a“cross-
validation” procedure was undertaken. Initially, ﬁve spectra
were randomly chosen and excluded from the training set
and used then as the veriﬁcation set. From 10 combinations
and 10 independent networks trained, in only two cases
were any of the 5 spectra classiﬁed as unknown, Table 1.
These results are encouraging; two cases represent ∼4% of
the total, so for (72, 6, 4) the classiﬁcation was veriﬁed
as 96% successful. The failures may have arisen due to an
insuﬃcient number of spectra in the training set or because6 Journal of Biomedicine and Biotechnology
Table 1: Results of cross-validation veriﬁcation process for the three- and four-layer ANN networks.
Architecture (72, 6, 4)∗
Veriﬁcation set no. Spectra used in veriﬁcation set Results of Classiﬁcation
1 2, 13, 17, 27, 38 all correct
2 21, 24, 31, 35, 51 all correct
3 4, 12, 22, 35, 44 spec. 35 classiﬁed as unknown
4 16, 17, 22, 25, 52 all correct
5 15, 16, 17, 23, 54 all correct
6 9, 15, 20, 24, 43 spec. 9 classiﬁed as unknown
7 3, 12, 15, 25, 51 all correct
8 19, 21, 43, 47, 54 all correct
9 16, 36, 37, 47, 48 all correct
10 12, 42, 44, 48, 50 all correct
Architecture (72, 4, 3, 4)
1 5, 13, 20, 21, 22, 23, 24, 31, 51, 54 all correct
2 5, 8, 12, 15, 16, 29, 35, 36, 42, 49 all correct
3 8, 10, 13, 18, 23, 28, 33, 39, 40, 53 all correct
4 3, 5, 7, 9, 17, 27, 41, 45, 50, 52 all correct
5 5, 11, 16, 14, 20, 22, 24, 26, 44, 50 all correct
∗where (72, 6, 4) refers to (the no. of inputs, the number of nodes in the hidden layer(s), the number of outputs).
networks with three layers have insuﬃcient complexity for
100% prediction accuracy, in this case.
3.5. 4-Layers Architecture. We then examined networks with
four layers (2 hidden). From several cases examined, it was
foundthatfour-layerANNarchitecturesperformedsimilarly
to simpler three layers architectures. Networks of the form
(72, 4, 3, 4) or (72, 5, 4, 4) were investigated, note that
the numbers in brackets refer to the number of inputs, the
number of nodes in the ﬁrst and in the second hidden
layers, and the number of outputs. Acceptable RMS values,
of 1.22 × 10−3 and 1.41 × 10−3 were obtained for (72, 4,
3, 4) and (72, 5, 4, 4), respectively, which are similar to the
values obtained using the optimal three-layer architecture.
Networks with the architecture (72, 4, 3, 4) performed very
similarly to (72, 5, 4, 4) and require fewer unknowns (or
weights, wij), 312 as opposed to 396. As a result, (72, 4, 3,
4 )w a sf o u n dt oc o n v e r g ef a s t e ra n dt ob el e s ss e n s i t i v et o
the number of spectra excluded from training to form the
veriﬁcation set. In fact, we found that 5 to 10 samples could
be used for veriﬁcation with 100% correct classiﬁcation of
the spectra, see Table 1. So in summary, the optimal 3- and
4-layer architectures were found to be (72, 6, 4) and (72, 4, 3,
4), respectively, Figure 5.
4. Discussion
The 1H NMR spectra of intact cells for both G1 13 21
and G2 17 33 have similar general appearance with severe
signal overlap and line broadening. Reprojection of either
data set, using PCA, demonstrates that separation by cell
types is possible due to systematic diﬀerences in the lipid
methylene and lactate methyl resonances and the overlapped
N-methyl 1H nuclei of the choline-containing species [24].
Alterations in signal intensity and chemical shift from such
cellular metabolites and biochemical intermediates have
been described by other researchers in the area [6, 11].
However, because of the complex biochemical role played by
these substances, we cannot ascribe a particular functional
role to the ﬁndings, what is more the alterations appear to
correlate and associate with particular phenotypic changes,
for example, drug resistance. On the basis of the principal
component analysis of either group, one could speculate
that metabolite proﬁling by in vivo MRS has potential
applications in monitoring the development of resistance in
a given cancerous tissue. However, for the full data set such
a possibility is eﬀectively prevented by other inﬂuences on
the metabolite distribution, which are comparable to, and
nonorthogonal with, the “relevant” biochemical variation.
We have shown that this signiﬁcant obstacle can be elimi-
nated, at least for in vitro studies of cell culture, by using
a suitable ANN architecture. The most successful network
was a four-layer structure with two hidden layers. After
appropriate training, the (72, 4, 3, 4) architecture enabled
100% successful classiﬁcation. Our approach may, in time,
be expanded to the classiﬁcation of larger data sets of spectra
which have been recorded with less stringent control over
sources of variance unrelated to the classiﬁcation of interest.
This result is encouraging and it is, to our knowledge, the
ﬁrst reported application of the use of ANNs speciﬁcally
to correctly classify 1H NMR spectra in a data set when
additional “nonrelevant” sources of variance are included.
Other related examples of the combination of supervised
and unsupervised methods include a report by Griﬃths and
coworkers [34], who obtained 85% accurate classiﬁcation
of meningiomas from nonmeningiomas, by initially using
PCA to reduce the dimensionality of 1H NMR spectra
recorded for tumor biopsy extracts. The ﬁrst thirty PCsJournal of Biomedicine and Biotechnology 7
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Figure 5: (a) Structure of the optimal 3-layer ANN architecture (72, 6, 4). (b) Structure of the optimal 4-layer ANN architecture (72, 3, 4).
from this ﬁrst stage of analysis were then classiﬁed using a
network. More recently, the performance of lineshape ﬁtting
and quantitative ANN analyses were compared by Hiltunen
et al. [35]f o rb o t hin vivo and simulated 1Hs p e c t r a .T h e
good correlation obtained with these two approaches, for
simulated data at least, suggested that ANNs have potential
for quantiﬁcation of in vivo MRS long echo time spectra. A
further advantage of ANNs in the development of analysis
methods for in vivo MRS is that they require less processing
time than line ﬁtting or other computational approaches
[36]. Thus, our study adds to the growing number of
applications of supervised techniques for exploiting the
diagnostic potential of 1H NMR spectra for biomedical
purposes.
5. Conclusions
We have found that NMR data recorded for human lung
carcinoma whole-cell culture samples can be used for anal-
ysis and classiﬁcation. When sources of variation not directly
related to the biological state of interest (drug resistance)
are minimised or kept constant, visual separation of the cell
type can be achieved using unsupervised pattern recognition
techniques, such as PCA. On the other hand, when this
condition is not met, in our case when diﬀerent researchers
were responsible for cell culture and spectroscopy, successful
classiﬁcationofthecelltypecouldbeachievedusingartiﬁcial
neural networks. The experimental and ANN methodology
developed are a step towards the goal of robust and reliable
diagnostics based on magnetic resonance spectral data.
Furthermore, as similar experimental problems may be
encountered in metabolomics applications using other spec-
troscopic techniques, biological classiﬁcation using ANNs of
data sets that include “nonbiological” sources of variance
may be generally possible.
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